News

Article

GE Healthcare Life Sciences and Emerson Collaborate in Biopharma Manufacturing

GE Healthcare Life Sciences and Emerson Process Management collaborate in biopharmaceutical manufacturing processes.

GE Healthcare Life Sciences and Emerson Process Management, announced on Nov. 16, 2015 a collaboration aimed at increasing productivity and improving efficiency in the production of biopharmaceuticals, such as monoclonal antibodies and vaccines.

Biopharmaceutical manufacturers are increasingly looking to automate production processes, driven by the industry need to increase efficiency and reduce costs.

The companies will work to integrate Emerson’s DeltaV distributed control system with GE Healthcare’s enterprise offerings. The first DeltaV-driven GE Healthcare installation, which is expected to be complete before the end of the year, will be a FlexFactory, GE’s integrated manufacturing platform based on single-use technologies.

The DeltaV system will be offered as an automation control platform for GE’s single-use bioprocessing offerings. 

Source: GE Healthcare Life Sciences

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Related Content